StockClub

LYRA

LYRALyra Therapeutics, Inc.$ --
Lyra Therapeutics, Inc.

Lyra Therapeutics, Inc.

LYRA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
0M USD
YoY -96.7%
Operating Income
-7M USD
YoY +34.3%
Net Income
-7M USD
YoY +36.7%
EPS
-9.6$
YoY -5547.1%

Revenue

$398,000
FY2024 Q1$532,000
$532,000
Q1
FY2024 Q2$1.1M
$1.1M
Q2
FY2024 Q3$1.3M
$1.3M
Q3
FY2024 Q4$1.5M
$1.5M
Q4
FY2025 Q1$183,000
$183,000
Q1
FY2025 Q2$366,000
$366,000
Q2
FY2025 Q3$391,000
$391,000
Q3
FY2025 Q4$398,000
$398,000
Q4
Actual
$-1.1M (-74.1%)

Net Income

$-28.9M
FY2024 Q1$-22.5M
$-22.5M
Q1
FY2024 Q2$-70.6M
$-70.6M
Q2
FY2024 Q3$-82.5M
$-82.5M
Q3
FY2024 Q4$-93.4M
$-93.4M
Q4
FY2025 Q1$-8.5M
$-8.5M
Q1
FY2025 Q2$-16M
$-16M
Q2
FY2025 Q3$-22M
$-22M
Q3
FY2025 Q4$-28.9M
$-28.9M
Q4
Actual
+$64.5M (+69.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021MISS
Actual:$285,000
Est:$1M
FY2021MISS
$285,000
FY2022MISS
Actual:$1.4M
Est:$4.2M
FY2022MISS
$1.4M
FY2023MISS
Actual:$1.6M
Est:$1.8M
FY2023MISS
$1.6M
FY2024BEAT
Actual:$1.5M
Est:$1.5M
FY2024BEAT
$1.5M
FY2025MISS
Actual:$398,000
Est:$800,000
FY2025MISS
$398,000

Analyst Estimates